Total Return:-52.14%(TTM)
Over the latest trailing 12-month period, total return cagr is -52.14%. The comparable SPY value is +22.18%. Year-to-date total return is -47.62%. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in PODD
$93,283
(9.3x return)
Invested on May 15, 2007
Growth of $10,000 in SPY (S&P 500)
$68,554
(6.9x return)
Invested on May 15, 2007
Hypothetical Growth of $10,000
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
Recent Performance Indicators
YTD Total Return
-47.6%
1-Year Total Return
-52.1%
Current Dividend Yield
0.00%
Price CAGR vs. Total Return CAGR
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | (52.1%) | (52.1%) | — |
| 3 Years | (19.7%) | (19.7%) | — |
| 5 Years | (11.7%) | (11.7%) | — |
| 10 Years | +18.0% | +18.0% | — |
| 15 Years | +14.1% | +14.1% | — |
| 20 Years | — | — | — |
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy